Literature DB >> 28170472

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .

Allison W Kurian1, Kent A Griffith2, Ann S Hamilton3, Kevin C Ward4, Monica Morrow5, Steven J Katz6, Reshma Jagsi7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28170472      PMCID： PMC5530866          DOI： 10.1001/jama.2016.16918

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  5 in total

1.  Multigene Panel Testing in Oncology Practice: How Should We Respond?

Authors:  Allison W Kurian; James M Ford
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

2.  Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Authors:  Mary B Daly; Robert Pilarski; Jennifer E Axilbund; Michael Berry; Saundra S Buys; Beth Crawford; Meagan Farmer; Susan Friedman; Judy E Garber; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; P Kelly Marcom; Sofia D Merajver; Kenneth Offit; Tuya Pal; Huma Rana; Gwen Reiser; Mark E Robson; Kristen Mahoney Shannon; Elizabeth Swisher; Nicoleta C Voian; Jeffrey N Weitzel; Alison Whelan; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Rashmi Kumar; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2016-02       Impact factor: 11.908

3.  Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

Authors:  Nadine Tung; Nancy U Lin; John Kidd; Brian A Allen; Nanda Singh; Richard J Wenstrup; Anne-Renee Hartman; Eric P Winer; Judy E Garber
Journal:  J Clin Oncol       Date:  2016-03-14       Impact factor: 44.544

Review 4.  A systematic review of factors that act as barriers to patient referral to genetic services.

Authors:  Türem Delikurt; Graham R Williamson; Violetta Anastasiadou; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2014-09-10       Impact factor: 4.246

5.  Performance of BRCA1/2 mutation prediction models in Asian Americans.

Authors:  Allison W Kurian; Gail D Gong; Nicolette M Chun; Meredith A Mills; Ashley D Staton; Kerry E Kingham; Beth B Crawford; Robin Lee; Salina Chan; Susan S Donlon; Yolanda Ridge; Karen Panabaker; Dee W West; Alice S Whittemore; James M Ford
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544
  5 in total
  48 in total

1.  Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.

Authors:  Allison W Kurian; Kevin C Ward; Nadia Howlader; Dennis Deapen; Ann S Hamilton; Angela Mariotto; Daniel Miller; Lynne S Penberthy; Steven J Katz
Journal:  J Clin Oncol       Date:  2019-04-09       Impact factor: 44.544

2.  Asian Americans respond less favorably to excitement (vs. calm)-focused physicians compared to European Americans.

Authors:  Tamara Sims; Birgit Koopmann-Holm; Henry R Young; Da Jiang; Helene Fung; Jeanne L Tsai
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2017-07-17

3.  A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.

Authors:  Erica M Bednar; Holly D Oakley; Charlotte C Sun; Catherine C Burke; Mark F Munsell; Shannon N Westin; Karen H Lu
Journal:  Gynecol Oncol       Date:  2017-06-10       Impact factor: 5.482

Review 4.  Genetic cancer predisposition syndromes among older adults.

Authors:  Yanin Chavarri-Guerra; Thomas P Slavin; Ossian Longoria-Lozano; Jeffrey N Weitzel
Journal:  J Geriatr Oncol       Date:  2020-01-21       Impact factor: 3.599

5.  Persistent Underutilization of BRCA1/2 Testing Suggest the Need for New Approaches to Genetic Testing Delivery.

Authors:  Anne Marie McCarthy
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

6.  Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Authors:  Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters
Journal:  Contemp Clin Trials       Date:  2018-09-18       Impact factor: 2.226

7.  BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.

Authors:  Amy L Gross; William J Blot; Kala Visvanathan
Journal:  JAMA       Date:  2018-08-14       Impact factor: 56.272

8.  National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.

Authors:  Christopher P Childers; Kimberly K Childers; Melinda Maggard-Gibbons; James Macinko
Journal:  J Clin Oncol       Date:  2017-08-18       Impact factor: 44.544

9.  Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer.

Authors:  Carlos H Barcenas; Maryam N Shafaee; Arup K Sinha; Akshara Raghavendra; Babita Saigal; Rashmi K Murthy; Ashley H Woodson; Banu Arun
Journal:  J Natl Compr Canc Netw       Date:  2018-05       Impact factor: 11.908

10.  Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.

Authors:  Maija Reblin; Monica L Kasting; Kelli Nam; Courtney L Scherr; Jongphil Kim; Ram Thapa; Cathy D Meade; M Catherine Lee; Tuya Pal; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Breast J       Date:  2018-11-28       Impact factor: 2.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.